Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)

Explore clinical trials studying Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) trial results

Completed

Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment

NCT01262482

Conditions
Adenocarcinoma, Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment), Carcinoma, +7 more
Locations
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Sant Pau Barcelona, Spain
  • H. Josep Trueta Girona, Spain
  • Centro Oncológico M.D. Anderson Spain Madrid, Spain
View Trial Details

Related conditions